Human papillomavirus 42 drives digital papillary adenocarcinoma and elicits a germ-cell like program conserved in HPV-positive cancers.
Lukas LeiendeckerTobias NeumannPauline S JungShona M CroninThomas L SteinackerAlexander SchleifferMichael SchutzbierKarl MechtlerKervarrec ThibaultEstelle LaurentKamel BachiriEtienne CoyaudRajmohan MuraliKlaus J BusamBabak Itzinger-MonshiReinhard KirnbauerLorenzo CerroniEduardo CalonjeArno RuttenFrank StubenrauchKlaus Georg GriewankThomas WiesnerAnna C ObenaufPublished in: Cancer discovery (2022)
The skin is exposed to viral pathogens, but whether they contribute to the oncogenesis of skin cancers has not been systematically explored. Here we investigated 19 skin tumor types by analyzing off-target reads from commonly available next-generation sequencing data for viral pathogens. We identified human papillomavirus 42 (HPV42) in 96% (n = 45/47) of digital papillary adenocarcinoma (DPA), an aggressive cancer occurring on the fingers and toes. We show that HPV42, so-far considered a non-oncogenic, "low-risk" HPV, recapitulates the molecular hallmarks of oncogenic, "high-risk" HPVs. Using machine learning, we find that HPV-driven transformation elicits a germ cell-like transcriptional program conserved throughout all HPV-driven cancers (DPA, cervical carcinoma, and head and neck cancer). We further show that this germ cell-like transcriptional program, even when reduced to the top 2 genes (CDKN2A, SYCP2), serves as a fingerprint of oncogenic HPVs with implications for early detection, diagnosis, and therapy of all HPV-driven cancers.
Keyphrases
- germ cell
- high grade
- transcription factor
- cervical cancer screening
- quality improvement
- squamous cell carcinoma
- sars cov
- gene expression
- machine learning
- genome wide
- wound healing
- stem cells
- dna methylation
- radiation therapy
- high resolution
- young adults
- childhood cancer
- cell therapy
- squamous cell
- multidrug resistant
- quality control
- rectal cancer